| D-0540-2024 | Class III | Cephalexin for Oral Suspension, USP, 250mg/5mL, Rx only, 200mL (when mixed), Each contains cephalexi | May 10, 2024 |
| D-0538-2024 | Class III | Cephalexin for Oral Suspension, USP, 250mg/ 5mL, Rx only, 200mL (when mixed), Each contains cephalex | May 10, 2024 |
| D-0539-2024 | Class III | Cephalexin for Oral Suspension, USP, 250mg per 5mL, Rx only, 100mL (when mixed), Each contains cepha | May 10, 2024 |
| D-0537-2024 | Class III | Cephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 200mL (when mixed), Each contains: ceph | May 10, 2024 |
| D-0536-2024 | Class III | Cephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 100 Tablets, Relabeled by: Bryant Ranch | May 10, 2024 |
| D-0556-2023 | Class III | Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (63629-8755-1), | April 20, 2023 |
| D-1188-2022 | Class I | Morphine Sulfate extended-Release Tablets, USP; 60 mg, 100-count bottles, Rx only, manufactured by: | June 17, 2022 |
| D-1187-2022 | Class I | Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufactured by: | June 17, 2022 |
| D-1029-2018 | Class II | Valsartan 320 mg tablets, 90-count bottles ( NDC 71335-0567-2), Rx Only, Packaged by Bryant Ranch, B | July 27, 2018 |
| D-1027-2018 | Class II | Valsartan 80 mg tablets, 90-count bottles (NDC 63629-6922-2), 60-count bottles ( 63629-6922-3), 28-c | July 27, 2018 |
| D-1028-2018 | Class II | Valsartan 320 mg tablets, 30-count bottles ( NDC 63629-6905-1), 90-count bottles (NDC 63629-6905-2), | July 27, 2018 |
| D-0837-2016 | Class III | Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b | March 25, 2016 |